1662724 2172250 17918772 3011082 7859516 1850298 15715983 2702982 2158562 2539251 2160032 12806432 9507531 1963290 2549853 1363724 2842045 2823823 7911742 1374646 3024817 3006680 9533538 8010996 3000380 2561099 11597574 1698074 2828121 2659197 303830 - Search Results

Year	Number of Results
1985	1
1986	7
1987	12
1988	12
1989	13
1990	9
1991	8
1992	4
1993	6
1994	11
1995	1
1996	6
1997	6
1998	1
1999	1
2000	1
2001	3
2002	3
2003	1
2005	2
2008	1
2010	2
2012	2
2023	0

1

Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Zhou XM, Wang ZQ, Chang JY, Chen HX, Cheng YC, Lee KH. Zhou XM, et al. J Med Chem. 1991 Dec;34(12):3346-50. doi: 10.1021/jm00116a001. J Med Chem. 1991. PMID: 1662724

2

Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site.

Hertzberg RP, Busby RW, Caranfa MJ, Holden KG, Johnson RK, Hecht SM, Kingsbury WD. Hertzberg RP, et al. J Biol Chem. 1990 Nov 5;265(31):19287-95. J Biol Chem. 1990. PMID: 2172250 Free article.

3

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy.

Kanemura N, Tsurumi H, Kasahara S, Hara T, Yamada T, Sawada M, Goto N, Kitagawa J, Shimizu M, Oyama M, Moriwaki H. Kanemura N, et al. Hematol Oncol. 2008 Mar;26(1):33-8. doi: 10.1002/hon.834. Hematol Oncol. 2008. PMID: 17918772

4

Proliferation dependence of topoisomerase II mediated drug action.

Sullivan DM, Glisson BS, Hodges PK, Smallwood-Kentro S, Ross WE. Sullivan DM, et al. Biochemistry. 1986 Apr 22;25(8):2248-56. doi: 10.1021/bi00356a060. Biochemistry. 1986. PMID: 3011082

5

Differential sensitivity patterns in small cell lung cancer cell lines: detection and circumvention of resistance to topoisomerase II targeting drugs.

Jensen PB. Jensen PB. Dan Med Bull. 1994 Nov;41(5):475-88. Dan Med Bull. 1994. PMID: 7859516 Review. No abstract available.

6

Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.

Zwelling LA, Mayes J, Hinds M, Chan D, Altschuler E, Carroll B, Parker E, Deisseroth K, Radcliffe A, Seligman M, et al. Zwelling LA, et al. Biochemistry. 1991 Apr 23;30(16):4048-55. doi: 10.1021/bi00230a032. Biochemistry. 1991. PMID: 1850298

7

Anti-trypanosomal activities of DNA topoisomerase inhibitors.

Deterding A, Dungey FA, Thompson KA, Steverding D. Deterding A, et al. Acta Trop. 2005 Mar;93(3):311-6. doi: 10.1016/j.actatropica.2005.01.005. Acta Trop. 2005. PMID: 15715983

8

Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro.

Finlay GJ, Baguley BC. Finlay GJ, et al. Eur J Cancer Clin Oncol. 1989 Feb;25(2):271-7. doi: 10.1016/0277-5379(89)90019-9. Eur J Cancer Clin Oncol. 1989. PMID: 2702982

9

Antitumor agents. 111. New 4-hydroxylated and 4-halogenated anilino derivatives of 4'-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Lee KH, Beers SA, Mori M, Wang ZQ, Kuo YH, Li L, Liu SY, Chang JY, Han FS, Cheng YC. Lee KH, et al. J Med Chem. 1990 May;33(5):1364-8. doi: 10.1021/jm00167a013. J Med Chem. 1990. PMID: 2158562

10

Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.

Adlakha RC, Ashorn CL, Chan D, Zwelling LA. Adlakha RC, et al. Cancer Res. 1989 Apr 15;49(8):2052-8. Cancer Res. 1989. PMID: 2539251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results